See more : Basin Energy Limited (BSN.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Star Combo Pharma Limited (S66.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Star Combo Pharma Limited, a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- BioQuest Corp. (BQST) Income Statement Analysis – Financial Results
- PWP Forward Acquisition Corp. I (FRWAW) Income Statement Analysis – Financial Results
- Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SS) Income Statement Analysis – Financial Results
- Enea AB (publ) (0RP6.L) Income Statement Analysis – Financial Results
- Shangri-La Asia Limited (0069.HK) Income Statement Analysis – Financial Results
Star Combo Pharma Limited (S66.AX)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.starcombo.com.au
About Star Combo Pharma Limited
Star Combo Pharma Limited engages in the manufacturing and distribution of health food products and nutritional supplements in Australia and China. The company operates in two segments, Star Combo and Austoyou Retail. It develops, manufactures, markets, and sells natural health supplements and skin care products. The company provides its products through e-commerce platform to Chinese health product consumers; and two retail stores in Sydney. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 26.02M | 24.70M | 22.88M | 26.72M | 38.84M | 21.41M | 10.75M | 9.79M | 9.35M | 6.70M | 5.06M |
| Cost of Revenue | 20.58M | 17.54M | 17.27M | 22.12M | 33.55M | 17.73M | 6.17M | 5.85M | 4.94M | 5.28M | 3.64M |
| Gross Profit | 5.44M | 7.16M | 5.61M | 4.61M | 5.29M | 3.68M | 4.58M | 3.94M | 4.41M | 1.42M | 1.42M |
| Gross Profit Ratio | 20.90% | 28.99% | 24.51% | 17.25% | 13.62% | 17.17% | 42.62% | 40.25% | 47.16% | 21.19% | 28.12% |
| Research & Development | 0.00 | 0.00 | 146.72K | 146.72K | 146.72K | 48.91K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 5.08M | 3.26M | 3.90M | 4.39M | 4.72M | 4.51M | 4.25M | 1.25M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 684.04K | 527.25K | 640.87K | 697.22K | 1.01M | 1.87M | 1.59M | 170.02K | 0.00 | 0.00 | 0.00 |
| SG&A | 4.72M | 3.79M | 4.54M | 5.09M | 5.73M | 6.38M | 5.84M | 1.36M | 1.08M | 464.02K | 494.42K |
| Other Expenses | 0.00 | 54.44K | 2.01M | 2.12M | 1.96M | 98.61K | 167.90K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.72M | 6.33M | 6.55M | 7.20M | 7.69M | 6.48M | 6.97M | 1.36M | 1.08M | 1.09M | 843.34K |
| Cost & Expenses | 25.30M | 23.87M | 23.82M | 29.32M | 41.24M | 24.21M | 12.38M | 7.21M | 6.02M | 6.37M | 4.48M |
| Interest Income | 261.21K | 128.40K | 52.22K | 106.08K | 1.02K | 87.48K | 118.91K | 105.68K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 196.14K | 186.87K | 171.47K | 235.72K | 393.87K | 26.62K | 104.16K | 105.68K | 82.22K | 0.00 | 0.00 |
| Depreciation & Amortization | 1.59M | 740.36K | 783.46K | 832.45K | 864.78K | 377.53K | 271.32K | 265.67K | 241.81K | 16.25K | 10.71K |
| EBITDA | 2.79M | -2.53M | -126.71K | -6.40M | 352.23K | -1.93M | -1.46M | 2.72M | 3.57M | 348.20K | 591.39K |
| EBITDA Ratio | 10.71% | 7.63% | 5.82% | -0.76% | 0.90% | -9.03% | -16.72% | 29.06% | 38.21% | 5.20% | 11.68% |
| Operating Income | 723.44K | 1.14M | 549.23K | -889.82K | -512.54K | -2.31M | -2.07M | 2.58M | 3.33M | 331.94K | 580.67K |
| Operating Income Ratio | 2.78% | 4.63% | 2.40% | -3.33% | -1.32% | -10.80% | -19.24% | 26.35% | 35.63% | 4.95% | 11.47% |
| Total Other Income/Expenses | 277.63K | -4.29M | -137.27K | -4.72M | 1.50M | 463.74K | -209.84K | -234.25K | -766.57K | 0.00 | 0.00 |
| Income Before Tax | 1.00M | -3.45M | -1.08M | -7.46M | -906.41K | -2.34M | -2.17M | 2.34M | 2.57M | 331.94K | 580.67K |
| Income Before Tax Ratio | 3.85% | -13.99% | -4.73% | -27.93% | -2.33% | -10.92% | -20.21% | 23.95% | 27.43% | 4.95% | 11.47% |
| Income Tax Expense | 253.73K | 548.04K | -385.28K | 412.52K | -557.73K | -611.20K | -199.15K | 708.94K | 746.48K | 95.51K | 173.36K |
| Net Income | 747.33K | -4.00M | -696.35K | -7.88M | -348.69K | -1.73M | -1.97M | 1.64M | 1.82M | 236.44K | 407.31K |
| Net Income Ratio | 2.87% | -16.21% | -3.04% | -29.47% | -0.90% | -8.07% | -18.36% | 16.71% | 19.45% | 3.53% | 8.04% |
| EPS | 0.01 | -0.03 | -0.01 | -0.06 | 0.00 | -0.02 | -0.03 | 0.02 | 0.02 | 0.00 | 0.00 |
| EPS Diluted | 0.01 | -0.03 | -0.01 | -0.06 | 0.00 | -0.02 | -0.03 | 0.02 | 0.02 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 135.08M | 135.08M | 134.58M | 134.79M | 91.42M | 82.14M | 62.66M | 75.62M | 75.62M | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 135.08M | 135.08M | 134.58M | 134.79M | 91.42M | 82.14M | 62.66M | 75.62M | 75.62M | 0.00 | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports